As per the published literature, SNHG6 can impact cisplatin resistance in gastric cancer (15, 26), 5-FU resistance in colorectal cancer (14), paclitaxel resistance in prostate cancer (16) as well as radio-resistance in cervical cancer (13). Here, SNHG6 is linked to Familial prostate cancer.